Develops methods to engineer and recode genes across the human microbiome, a complex and previously unsolved challenge in biotechnology. This technology aims to create tailored personal care ingredients that leverage microbiome modulation for improved skin health and functionality.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Engineering and modifying genes within the human microbiome presents a significant challenge in biotechnology due to its complexity and diversity. Traditional methods struggle to reliably recode genes across the vast array of microbial species present in the microbiome.
Solution
The company is developing novel methods to engineer and recode genes across the human microbiome. This technology enables the creation of tailored personal care ingredients by modulating the microbiome to enhance skin health and functionality. By precisely targeting and altering specific genes within the microbiome, the company aims to develop personalized solutions for various skin conditions and improve overall skin health. The approach focuses on harnessing the power of the microbiome to create innovative and effective personal care products.
Target Audience
The primary target audience includes personal care product manufacturers seeking innovative ingredients and solutions for enhanced skin health.
Features
- Development of methods for targeted gene editing within the human microbiome.
- Creation of tailored personal care ingredients through microbiome modulation.
- Focus on improving skin health and functionality through microbiome engineering.